This HTML5 document contains 142 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://dx.doi.org/10.1002/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q41716870
rdf:type
wikibase:Item
schema:description
სამეცნიერო სტატია 2015年論文 artigo científico 2015年論文 scientific article published on 22 May 2015 wissenschaftlicher Artikel научная статья ২২ মে ২০১৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ articol științific 2015年论文 scientific article published on 22 May 2015 2015년 논문 2015年论文 bilimsel makale article scientific vitenskapelig artikkel 2015年論文 scientific article published on 22 May 2015 article científic vetenskaplig artikel 2015年论文 teaduslik artikkel vedecký článok artikulong pang-agham videnskabelig artikel 2015年論文 мақолаи илмӣ artikel ilmiah научни чланак научна статия 2015 nî lūn-bûn bài báo khoa học บทความทางวิทยาศาสตร์ article scientifique 2015年论文 artículu científicu espublizáu en 2015 2015年论文 artigo científico מאמר מדעי tudományos cikk naučni članak articolo scientifico artikull shkencor наукова стаття, опублікована в травні 2015 2015年の論文 tieteellinen artikkeli wetenschappelijk artikel επιστημονικό άρθρο مقالة علمية نشرت في 22 مايو 2015 artículo científico publicado en 2015 научни чланак artykuł naukowy 2015年論文 scienca artikolo vitskapeleg artikkel vědecký článek artigo científico 2015年论文
p:P577
wds:Q41716870-4A2DCBAE-3DFD-468D-83EE-2DA06D1BCB95
wdt:P577
2015-05-22T00:00:00Z
p:P2860
wds:Q41716870-FA23A4FE-5B89-4E9B-A330-44D8BC7DBB5E wds:Q41716870-FCBCD6E6-F549-4244-890A-C4998B65B796 wds:Q41716870-FECACB3D-3B92-4B22-9ABF-F52906A6A537 wds:Q41716870-C3E7776F-8D4B-4963-8A50-00DF9B485A8D wds:Q41716870-CF7DB09B-01F6-4C5A-AC44-223828C8D439 wds:Q41716870-D67B5ECD-3261-49AE-AFA4-1C5753BD7269 wds:Q41716870-EDC14947-89FE-48F9-B659-DA37A5F8F159 wds:Q41716870-93ECAE7C-C573-4990-A160-03EF3C7759BB wds:Q41716870-949668E5-0E0D-4DC9-89A4-A1CCDFCB3B27 wds:Q41716870-AAA7BC92-0CE8-437F-AFFA-FA19B4CD287D wds:Q41716870-AB68990B-F83E-408A-A04D-ACA410DB516A wds:Q41716870-B4A9A697-F668-4746-B950-08F95DF4AF09 wds:Q41716870-7DEB491A-EEE1-4C3E-9649-82432AD211C8 wds:Q41716870-8C9BEA93-38CD-410C-AF12-5015DB13D729 wds:Q41716870-29D9EE07-B334-47EC-A8B5-151011E8462B wds:Q41716870-186ED050-DE9B-4C3E-91B3-8F0CD7AF2CA7 wds:Q41716870-1EDBB7AD-5415-40FB-AD45-3E1D4CBAE094 wds:Q41716870-27AD3EE8-9A96-4D38-8940-B3EB284CF470
wdt:P2860
wd:Q28269340 wd:Q46891646 wd:Q28170627 wd:Q58973820 wd:Q38072506 wd:Q47240592 wd:Q28246190 wd:Q47438826 wd:Q45173221 wd:Q43826666 wd:Q28281179 wd:Q50602241 wd:Q28210982 wd:Q36691794 wd:Q43877849 wd:Q38376864 wd:Q46779284 wd:Q38448533
p:P2093
wds:Q41716870-77E1DA7A-DB75-4FAD-9993-A88DC04DC302 wds:Q41716870-47F72BBC-AA8C-41B2-AD5B-CAE3926CC5E6
wdt:P2093
Christopher Meduri C Michael Gibson
rdfs:label
Bivalirudin is associated with improved clinical and economic outcomes in heart failure patients undergoing percutaneous coronary intervention: Results from an observational database
skos:prefLabel
Bivalirudin is associated with improved clinical and economic outcomes in heart failure patients undergoing percutaneous coronary intervention: Results from an observational database
schema:name
Bivalirudin is associated with improved clinical and economic outcomes in heart failure patients undergoing percutaneous coronary intervention: Results from an observational database
p:P50
wds:Q41716870-D9225FCD-A652-426A-87CF-0F383E76C562 wds:Q41716870-E3AB2E07-ADCA-4D8D-83D7-121BD99AA9CF wds:Q41716870-CFE058EE-31E6-468B-9F78-5D7527187A01 wds:Q41716870-49EEE94B-2145-42B9-87B8-6E6307C238D2 wds:Q41716870-28C30BD8-1BB8-4965-9363-A3445EDD0673 wds:Q41716870-53D9806F-7492-4C7B-A589-ECDFA2B75DDE wds:Q41716870-57218C35-977A-4703-82A3-02A1ADDBED66 wds:Q41716870-B5F53B9C-7401-4A2E-963F-3E2A34FA1D80 wds:Q41716870-B7AA4FEF-418B-4001-9CCF-7BE10D54A8D0
wdt:P50
wd:Q90754539 wd:Q41554552 wd:Q114304269 wd:Q88567579 wd:Q71301800 wd:Q114304264 wd:Q114292257 wd:Q93141120 wd:Q95630196
p:P1476
wds:Q41716870-57A17724-2FEC-477A-8F72-EBA10F3B8323
wdt:P1476
Bivalirudin is associated with improved clinical and economic outcomes in heart failure patients undergoing percutaneous coronary intervention: Results from an observational database
p:P304
wds:Q41716870-59241C29-DC92-47F1-8FC2-C957028CB829
wdt:P304
363-373
p:P31
wds:Q41716870-BAF68E49-EC36-4C37-B49A-76C207C7ADAA
wdt:P31
wd:Q13442814
p:P698
wds:Q41716870-0BF3DFF6-8D7D-4225-915B-9EF8FDD76800
wdtn:P698
n8:26011467
wdt:P698
26011467
p:P1433
wds:Q41716870-376BCBD6-E3A3-4D71-ABCC-166BD349A8A8
wdt:P1433
wd:Q2352240
p:P433
wds:Q41716870-A5186897-7F24-497C-B8DC-65FA5CC855AF
p:P478
wds:Q41716870-4CB24149-89D3-4BBA-A78D-49D648011824
wdt:P433
3
wdt:P478
87
p:P356
wds:Q41716870-2B2C0CDF-1AEF-4B0D-ABEB-9648928F87E9
wdtn:P356
n9:CCD.26023
wdt:P356
10.1002/CCD.26023
p:P5875
wds:Q41716870-828731CB-1DB0-4FCE-883D-62063083A680
wdt:P5875
277088549